-
Je něco špatně v tomto záznamu ?
Pulmonary Complications after COVID-19
P. Jakubec, K. Fišerová, S. Genzor, M. Kolář
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
DRO FNOL 00098892
University Hospital Olomouc
IGA_LF_2022_018
Palacký University Olomouc
AZV NU22-B-112
Czech Health Research Council
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
35330108
DOI
10.3390/life12030357
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5-11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22009906
- 003
- CZ-PrNML
- 005
- 20220425131622.0
- 007
- ta
- 008
- 220420s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/life12030357 $2 doi
- 035 __
- $a (PubMed)35330108
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Jakubec, Petr $u Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic $u Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc, I. P. Pavlova 185/6, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000261845731
- 245 10
- $a Pulmonary Complications after COVID-19 / $c P. Jakubec, K. Fišerová, S. Genzor, M. Kolář
- 520 9_
- $a Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute course, but also because of various complications occurring in the following period, that is, more than 28 days after the onset of acute infection. The present study identified a total of 121 patients hospitalized 29 or more days after the first positive result of a PCR test for SARS-CoV-2, of whom 98 patients were included in the study. Patients were divided into two groups by the time interval between the positive COVID-19 test result and hospitalization date. The time intervals were week 5-11 in an ongoing-COVID group (57.1% of patients) and 12 or more weeks in a post-COVID-group (42.9%). The most frequent reason for hospitalization was respiratory tract infection (58.2%). Pneumonia accounted for 77.2% of these cases. Other reasons for hospitalization were interstitial lung disease (22.4%), pulmonary embolism (8.2%), and sarcoidosis (6.1%). The study group was further divided according to the causes of hospitalization into subgroups with infections and other causes. In the group with infectious diseases, there was a shorter time period between PCR positivity and hospitalization and there were significantly more frequent non-respiratory complications. In the entire sample, the in-hospital mortality was 5.1%.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fišerová, Kateřina $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic
- 700 1_
- $a Genzor, Samuel $u Department of Pulmonary Diseases and Tuberculosis, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic $u Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc, I. P. Pavlova 185/6, 77900 Olomouc, Czech Republic
- 700 1_
- $a Kolář, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000346218868 $7 jn20010310083
- 773 0_
- $w MED00186366 $t Life (Basel, Switzerland) $x 2075-1729 $g Roč. 12, č. 3 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35330108 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220420 $b ABA008
- 991 __
- $a 20220425131620 $b ABA008
- 999 __
- $a ind $b bmc $g 1784435 $s 1161104
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 3 $e 20220228 $i 2075-1729 $m Life $n Life (Basel) $x MED00186366
- GRA __
- $a DRO FNOL 00098892 $p University Hospital Olomouc
- GRA __
- $a IGA_LF_2022_018 $p Palacký University Olomouc
- GRA __
- $a AZV NU22-B-112 $p Czech Health Research Council
- LZP __
- $a Pubmed-20220420